
The study involved 14,025 patients undergoing their initial percutaneous coronary intervention (PCI) exhibited multimorbidity, with hypertension (59%) and dyslipidaemia (60%) being prevalent. Clusters with distinctive multimorbidity patterns were identified, correlating with varying risks of 30-day and 12-month major adverse cardiac and cerebrovascular events (MACCE) post-PCI. Specific clusters demonstrated significantly higher risks, emphasizing the need for personalized treatment approaches to improve patient outcomes and quality of care.
Like
Save
Share